Clinical trial
Advancing Nimble Science's SIMBA GI Data Platform for Clinically Actionable Insights From the Small Intestine in Irritable Bowel Syndrome to Deliver Personalized Treatment
NCT07882953 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Advancing Nimble Science's SIMBA GI Data Platform for Clinically Actionable Insights From the Small Intestine in Irritable Bowel Syndrome to Deliver Personalized Treatment
- Lead sponsor
- University of Calgary
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- November 30, 2026
- Completion date
- September 30, 2028
- Enrollment
- 180 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
irritable bowel syndrome (ibs), microbiome